Womed
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2024-04-01attributed |
| Founded | 2018 |
| Headquarters | Medical Devices |
| Industry | healthtech |
| Stage | unknown |
| Website | omed.fr |
Womed develops intrauterine therapies built on a proprietary polymer, led by Womed Leaf, a barrier that prevents intrauterine adhesions after surgery. It targets women facing infertility, fibroids and abnormal bleeding. Its differentiator is the first physical-barrier device clinically shown to reduce adhesions.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-04-01 | grant | $2.7M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | omed.fr, read 2026-05-08 |
| Description | self-reported | omed.fr, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.